Just reported
From Resmed's results release of 29 अक्टूबर 2026; its quarterly report has since been filed.
Actual
$1.41B
+5.9% y/y
-3.3% q/q
Guided
—
No guide given
Actual
$2.92
+23% y/y
+11% q/q
Guided
—
No guide given
Actual
$453M
+1.4% y/y
+1.0% q/q
Guided
—
No guide given
Full year 2027
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
आमदनी के हिस्से quarter ended 2026-03-31 के अनुमान हैं, किसी दाख़िल रिपोर्ट के आँकड़े नहीं।
AirSense 11
A connected machine that delivers continuous or automatically adjusted air pressure to treat sleep apnea.
AirCurve 11
A bilevel breathing machine that provides different pressure levels for breathing in and out, for people needing more support or with complex breathing disorders.
Astral ventilators
Ventilators that provide breathing support, including for people receiving care at home.
AirTouch N30i, AirTouch F30i, and AirFit F40 masks
Masks that connect a person to a breathing machine during sleep; the named models include fabric and silicone designs.
myAir and AirView
Software for patients to engage with their sleep treatment and for providers to connect with and support patients.
Brightree and MEDIFOX DAN
Software products for residential care and home medical equipment providers.
ResMed makes devices that help people breathe during sleep and ventilators for people who need breathing support. It also sells masks and software for patients, medical equipment providers, and residential care providers. Its sleep products include machines that connect with patient and provider software.
Resmed Inc. की अपनी रिपोर्टों से बना, जो अमेरिकी प्रतिभूति और विनिमय आयोग (SEC) में दाखिल की गईं। आँकड़े जैसे बताए गए, और प्रति-शेयर इतिहास आज के शेयर आधार पर पुनर्गणित। यह एक व्यवसाय का वर्णन है — यह निवेश सलाह नहीं है और न ही कुछ खरीदने या बेचने की सिफ़ारिश।
The themes Resmed is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
RMD · NYSE · Healthcare · Medical Instruments and Supplies
$239.53+0.2%13 नव॰ बंद भाव
30 सितंबर 2026 तक के आँकड़े, 30 अक्टूबर 2026 को दाखिल 10-Q से
ResMed sells breathing machines and masks for sleep apnea and other breathing disorders to patients through medical equipment providers.
Grade B+
भाव के नीचे की पट्टी हर तारीख की ग्रेड दिखाती है, जो सिर्फ़ उस समय तक सार्वजनिक दस्तावेज़ों से बनी है।
Resmed Inc. के ग्रेड इतिहास की 41 तिमाहियों में से 2 दिखाई जा रही हैं। बाकी 39 अक्टूबर 2016 तक जाती हैं।